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CurrentUSpublicpolicydecisionswillhaveimpactonnationalplanstocarefortheagingAmericanbabyboomerpopulationover
the next several decades. The recent health care legislative debate has been largely about the structure of health care for those still
too young to be covered by Medicare, but the legislation may have important implications for the average rates of accumulating
chronic illness and disability in midlife and inﬂuence the care needs for that cohort of individuals even after they become elderly.
As we prepare for the aging of the American baby boomer
population,muchfocushascometotheissueoftheexpected
costs of providing that care, and this issue has ﬁgured promi-
nently in the ongoing discussions about implementation of
the recent national health care legislation. The future cost
of caring for an aging population can be decomposed into
three separate factors. The ﬁrst of these factors, the numbers
of middle-aged Americans poised to become elderly in the
next several decades, is essentially an immutable quantity.
The second factor, the cost of caring for each episode of
illness, has received much attention during the health care
debates of recent months, with a variety of strategies (such
as use of electronic health records to guide care, measures to
avoid duplicative laboratory tests, and increased resources to
ferret out healthcare fraud) being proposed to make health
care delivery more cost eﬀective.
The third factor of the equation, which has gotten much
less attention, is the average level of baseline health of the
older individual, which in turn drives the average amount
of care that needs to be delivered to a given older individual
per year. It may be particularly useful to focus on the subset
of health care interventions that represents “dominating”
strategies; that is, those interventions which produce an
improvement in public health at the same time that they
also save money. A focus on such dominating strategies can
oﬀeraninitial opportunity tobegin theprocessofexpanding
the health care safety net in a relatively painless fashion, to
precede the much more challenging task of making cost-
beneﬁt decisions about other health care eﬀorts that do not
save money but that are cost eﬀective.
The search for dominating strategies will become sub-
stantially easier to accomplish as the US Center for Medicare
and Medicaid Services (CMS) has recently announced
measures to encourage the “meaningful use” nationally of
electronic health records through provider incentives under
Medicare and Medicaid starting in 2011 [1, 2]. Care for the
elderlyunderMedicare,andfortheindigentunderMedicaid,
target two vulnerable subsets of the U.S. population who
often have complex medical care needs. These populations
might be especially beneﬁted by initiatives to use their
electronic health data to help deliver cost-eﬀective care to
them.
The meaningful electronic health record is intended
to ultimately include the BMI, blood pressure, an up-to-
date problem list, active medication list, ambulatory quality
measures, and some decision support rules among other fea-
tures. This new electronic record, combined with the current
interest in funding health care eﬀectiveness research, should
create an ideal environment to promote research eﬀorts
that can convincingly identify the dominating healthcare
strategies in caring for aging baby boomers.
Adults who lack insurance coverage prior to age of
65, and who thus have an economic disincentive to seek
health care in midlife, are likely to be higher users of2 Current Gerontology and Geriatrics Research
health care once they become eligible for Medicare coverage
[3]. Interventions in late midlife can favorably inﬂuence
healthcare costs into late life in a variety of ways. Lifestyle
interventions that produce durable behavioral change, such
as permanent smoking cessation, would have even more
health and economic beneﬁts the earlier in life they were
implemented. Even if a lifestyle behavioral change in late
midlife was only temporarily eﬀective, such as improving
adherence to an antihypertensive regimen for a year or two,
net beneﬁts could persist into old age (e.g., fewer individuals
turning age of 65 being already disabled by a remote prior
stroke). Finally, some surgical and other interventions made
in latemidlife willhaveintrinsic capability to remainin place
after age of 65, even if done long previously.
National health care policy can beneﬁt from more
attention to the process by which individuals transition into
Medicare eligibility [4]. Consider modeling the economic
and public health eﬀect of Medicare oﬀering to be the
secondary payor at age of 63 for individuals who are obese
diabetics as indicated by the combination, respectively, of
their electronic health record BMI, of diabetes as shown by
their diagnosis list, by a medication list containing insulin or
other diabetes-speciﬁc drugs, and/or by laboratory criteria
(hemoglobin A1c and/or blood glucose levels). In particular,
one would seek to follow up on the evidence in the recent
medical literature [5, 6] suggesting that bariatric surgery is
a dominating strategy for management of obese diabetics
based even on the savings that accrue within two years.
In this hypothetical example, assume that the actuarial
likelihood is that a typical 63-year-old obese diabetic would
still have a life expectancy greater than ten years, so that
in most cases they would yield two years of savings prior
to reaching age 65 (and current Medicare eligibility), and
typically greater than eight years of saving for ongoing
healthcare during the post-65 period of Medicare eligibility.
One might wish to include a modest adjustment to discount
to present (when patient’s age is 63) value for the savings
in the succeeding pre-Medicare and post-Medicare eligibility
periods.
In actual practice, of course, one would anticipate that
individuals with obvious life limiting conditions would not
be oﬀered or accept bariatric surgery, so that the cost of any
such surgical intervention would in clinical practice likely
be focused on the relatively healthier among the 63-year-
old obese diabetics, those who might have a relatively longer
life expectancy. Clinical care decisions that focus expensive
surgical interventions on those most likely to derive long-
term beneﬁt, in general, would translate at the societal level
into increased cost eﬀectiveness of the intervention.
Why have dominating healthcare strategies not been
more widely employed? In some cases, this failure represents
a lack of knowledge to identify clearly those strategies which
in fact are dominating. More research expenditures are now
being actively discussed to look at comparative eﬀectiveness
of interventions, and such studies should provide much data
to identify dominating healthcare strategies. Sound research
expenditures that enable more eﬀective use of health care
resources, spending millions on research to help us better
allocate billions on health care, are too likely to represent
economically dominating expenditures.
In some cases, the failure to adopt dominating healthcare
strategies may represent a consequence of disparate distri-
bution of costs and beneﬁts, so that a payor for example
may incur most of the cost of the health care intervention
yet reap only a fraction of the economic beneﬁts. A typical
examplewouldoccurinahealthcareinsurancemarketwhere
those insured frequently change from one insurer to another,
so that the current insurer has a primary economic interest
in minimizing current health care expenditures even at the
risk that this will lead to worsening future health outcomes
and higher future health care expenditures for the patient
currently insured by them, since the late future health care
expenditures are likely to be external to the current insurer’s
economic interest. A more global way of avoiding these
issues is to move to a single payor system that minimizes
such economic externalities. Short of that intervention, one
should look for ways to promote dominating healthcare
strategies as a societal good, regardless of whether the
implementation of the dominating strategy happens to be in
a particular economic interest of the speciﬁc present insurer.
If the American health care system should adopt a policy
of funding selected preventive health measures via Medicare
for those under age of 65, then there is a risk that this
may result in cost shifting for care from the current private
insurer to Medicare. One strategy to prevent this result
might be to allow Medicare to cover payment for select
healthcare interventions prior to age of 65, but only as the
secondary payor, so that those individuals under age of 65
with private insurance would primarily be covered by their
insurance company. Medicare in such cases might absorb
the deductible and copay, so that the dominating healthcare
intervention would in any event not result in an out-of-
pocket cost to the individual consumer.
Other more complex cost allocation schemes could
certainly be considered. One might for example adjust the
share to be paid by Medicare to be relatively higher if the
intervention was made when the patient was very nearly
at the age of Medicare eligibility, or if the patient were
of lower income, or if the patient had already incurred
signiﬁcant out-of-pocket healthcare costs that year. The
argument from a societal perspective is that dominating
healthcare expenditures are worth making, that their total
beneﬁttosocietyisgreaterthantheirtotalcosttosociety.The
decision of how to allocate those costs most fairly is certainly
important, but it is separate from and subsidiary to the fact
that the costs are worth incurring.
The strategy proposed here focuses on those individuals
approaching age of 65, but it has implications for both
older and younger segments of the population. On the one
hand, introduction of dominating healthcare strategies such
as lifestyle changes in middle age could tend to increase the
number of who survive to be among the oldest old [7–9].
This would have the cost eﬀect of increasing the number of
years of healthcare coverage required to support a prolonged
life expectancy into old age, but this is certainly a cost we
should be willing to accept.Current Gerontology and Geriatrics Research 3
On the other hand, introduction of a limited CMS role
to fund dominating healthcare approaches in midlife could,
if the country so chooses, later become the foundation for
public policy experience for expanding a yet broader role
for public support of healthcare to individuals below age of
65. In the current economic environment, one might choose
ﬁrsttopubliclyfundmidlifehealthcareinterventionsthatare
demonstrated to be dominating and so actually save money
in terms of lifetime healthcare costs, but then later expand
coverage to those additional midlife healthcare interventions
that are very cost eﬀective even though they do involve some
net expense.
Some of the most contentious issues in health care
policy today revolve around issues of resource allocation and
distributive justice. One point of contention is what fraction
of gross domestic product should be devoted to health care.
A second issue is how health care expenditures should be
allocated across generations; including whether health care
needs of the young should be favored over those of the old,
in order to maximize the number of life-years gained by
society for each dollar of health care expenditure. Yet, a third
concern is that national health care costs are growing faster
than the rate of inﬂation and faster than the rate of overall
growth in domestic product.
A focus on dominating healthcare strategies does not
resolve any of these three issues, but to some extent it can
sidestep each of them. Since an economically dominating
strategy by deﬁnition is one that saves money over the course
of time, that saving should tend to decrease the fraction
of gross domestic product spent on health care. Second,
interventions that produce long-term gains in health status
may be administered to the young, but still produce beneﬁts
that persist into old age. Finally, these dominating strategies
can help moderate the rate of rise in health care costs.
I would argue that an eﬀort to fund strategies identiﬁed
as dominating is useful as an overall approach, even rec-
ognizing that some strategies labeled as dominating will in
fact prove to have a net cost. Many of these errors are likely
to be cases where the prediction of domination was only
slightly oﬀ the mark, so that the net cost of the strategy will
be relatively small. As a result, an eﬀort to fund putatively
dominating strategies in practice is likely to direct funding
to a mixture of strategies, some of which will in fact be
dominating, and most of the rest of which will be highly cost
eﬀective.
Calculating whether a health care strategy is dominating
may depend on a number of assumptions, not only about
health care itself, but also about economics. If a costly health
care intervention only produces its savings beneﬁts many
years in the future, one might value that result less highly
the further in the future the beneﬁt will be realized. Should
the value of an intervention that produces long-delayed
future savings be discounted to reﬂect the present value of
those savings? If so, what discount rate should be applied;
a subjective discount rate chosen by survey, a discount rate
based on the long-term interest rate, or some other metric?
Formanyhealthcareinnovations,wemaysimplylackthe
data to do complete calculations of the most distant beneﬁts.
Consider the case of a new vaccine. The longer the duration
of protection from a dose of vaccine, the more likely it is that
use of the vaccine will be a dominating strategy.
At the time of initial approval of an innovative vaccine
product, the manufacturer is likely to have short-term data
on immunogenicity, safety, and eﬃcacy. There will not
probably be enough time to evaluate whether the initial dose
oﬀers lifetime protection, or whether the vaccination will
need to be repeated in 5–10 years to maintain protective
titers. One might try to extrapolate the rate of titer decline
at ten years based on the fall in titer in the initial years,
but this would be a speculative enterprise. On the other
hand, if the protective eﬀect of the vaccine can be shown
to yield enough health beneﬁt in the ﬁrst year or two to
fully cover the expense of the vaccine, then vaccination is
likely to be a dominating strategy regardless of whether the
vaccine protection extends unabated or whether it wanes in
subsequent years.
In a setting of rising health care expenditures and
limited resources, there has still been considerable reluctance
to confront hard tradeoﬀ situations where high costs are
associated with important health care beneﬁts. Eﬀorts to
control costs have often looked for easier cases ﬁrst. These
eﬀorts have often taken a sharply negative tone, looking at
ways to decrease “fraud, waste, and abuse,” however, the
particular speaker may deﬁne these terms. These eﬀorts
reﬂect in part an attempt to explore parts of the health care
budget where there is no tradeoﬀ, because the expenditure
doesn’t produce any real beneﬁt. Dominating health care
strategies represent the mirror image easy case, a positive
opportunity to secure societal health beneﬁt at no net
cost. Decision makers should be as diligent in working
to maximize the implementation of dominating healthcare
strategies as they have been in advocating to minimize fraud,
waste, and abuse.
Disclaimer
Personal opinions are those of the author, not oﬃcial.
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